Canadian Sciences Speakers Network

Réseau Canadien de Panélistes Scientifiques


Lisa Porter: CSSN Speaker

Lisa Porter

Windsor, ON

Position: Distinguished Professor

Organization: University of Windsor

Dr. Lisa Porter is passionate about the value that research excellence brings to the health and care of the community that we serve. She leads a team of scientists and students to find new and better ways to rapidly detect and treat cancer. She has a deep appreciation for the importance of multi-disciplinary, collaborative research conducted with patients and the community to ensure rapid and effective translation of results and knowledge which fosters innovation & impact in the healthcare system.

Areas of Expertise:

+ Cancer
+ Research communications
+ Health

Language(s):

+ English


About Me

English proficiency: Read, Write, Speak

Title: Dr.

Pronouns: She/Her/Hers

Gender: Female


Recent Publications

Title Year
Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis2025
Profiling Glioma Stem Cell Dynamics via 3D-Based Cell Cycle Reporter Assays2025
Modeling Glioma Stem Cell-Mediated Tumorigenesis Using Zebrafish Patient-Derived Xenograft Systems2025
Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects2024
Regulation of biological processes by ubiquitin ligases: a focus on the Pagano Lab’s contribution2024
Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis2024
High‐impact practices in cancer education and research: Undergraduate students’ perceptions of skills and career development2024
Abstract PO3-03-09: Clinical Significance of Grade in Triple Negative Breast Cancer2024
Su1134 TARGETED GENE SEQUENCING OF SPORADIC YOUNG-ONSET COLON CANCER SAMPLES USING TRUSIGHT ONCOLOGY 500 FROM ILLUMINA IDENTIFIES RECURRENT MUTATIONS IN DDR2 ONCOGENE.2024
Evaluating and optimizing Acid-pH and Direct Lysis RNA extraction for SARS-CoV-2 RNA detection in whole saliva2024
Presentation and Outcome of Patients with Multiple Myeloma (MM), Single Centre Experience from Windsor Essex Regional Cancer Centre2024
Comparative genomic analysis to identify a signature of sporadic colorectal cancer development in young adults.2024
EXPLORING THE INTERPLAY BETWEEN BRAIN TUMOUR INITIATING CELLS AND THE TUMOUR MICROENVIRONMENT: POTENTIAL TARGETING STRATEGIES FOR GLIOBLASTOMA2023
Actionable wastewater surveillance: application to a university residence hall during the transition between Delta and Omicron resurgences of COVID-192023
Abstract P4-07-60: Identification of Optimal Carboplatin Containing Regimen for Triple Negative Breast Cancer2023
Comprehensive gene sequencing to identify progression predictors to muscle-invasive bladder cancer.2023
Tuberin levels during cellular differentiation in brain development2022
Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells2022
Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments2022
Dissecting the roles of the Tuberin protein in the subcellular localization of the G2/M Cyclin, Cyclin B12022
Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles2022
Fitted filtration efficiency and breathability of 2-ply cotton masks: Identification of cotton consumer categories acceptable for home-made cloth mask construction2022
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer2022
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells2022
A revised synthesis of 6-alkoxy-2-aminopurines with late-stage convergence allowing for increased molecular complexity2022